Sign In
Buy COWN
$38.99
+0 (+0%)
At Close: May 26, 2023
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
04:05pm, Tuesday, 25'th Feb 2025
WEST CHESTER, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for ski
Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
04:05pm, Tuesday, 25'th Feb 2025
BOULDER, Colo. , Feb. 25, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development o
argenx to Present at TD Cowen 45th Annual Healthcare Conference
01:00am, Tuesday, 25'th Feb 2025
February 25, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, tod
Xilio Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
04:30pm, Monday, 24'th Feb 2025
WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies fo
atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
04:10pm, Monday, 24'th Feb 2025
NEW YORK and BERLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of
Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
04:05pm, Monday, 24'th Feb 2025
SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webca
Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference
04:03pm, Monday, 24'th Feb 2025
SAN JOSE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and comp
Bicara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
04:01pm, Monday, 24'th Feb 2025
BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients wi
Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference
04:01pm, Monday, 24'th Feb 2025
COPENHAGEN, Denmark, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the TD Cowen 45th Annual Health
Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference
09:08am, Monday, 24'th Feb 2025
REDWOOD CITY, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will participate in a fireside chat presentation
Inozyme Pharma to Present at the TD Cowen 45th Annual Health Care Conference
08:30am, Monday, 24'th Feb 2025
BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for ra
Nuvation Bio to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Monday, 24'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, Pre
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
08:00am, Monday, 24'th Feb 2025
CAMBRIDGE, Mass. , Feb. 24, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therap
Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference
08:00am, Monday, 24'th Feb 2025
BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic
Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025
08:00am, Monday, 24'th Feb 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr
